724.1000 -2.90 (-0.40%)
NSE Apr 21, 2025 15:27 PM
Volume: 307.1K
 

Angel Broking
Unique investment opportunity in drug research business: While almost all Indian pharma companies are in generic drugs business, Syngene supports its clients to invent new drugs. It has 8 of the top 10 global pharma companies as its clients and also has long term contracts with some big pharma companies. In our view Syngene provides a uni..
Syngene International Ltd. is trading below its 100 day SMA of 781.3
More from Syngene International Ltd.
Recommended